| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |